Viatris Inc. (VTRS) Provides Updates on Four Recent Regulatory Milestones [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
regulatory milestones spread across all stages of the company's global pipeline. It stated that the FDA approved the company's octreotide acetate for injectable suspension, which is a generic version of Sandostatin® LAR Depot and indicated for treatment in patients who have responded to and tolerated Sandostatin Injection subcutaneous injection for acromegaly, profuse watery diarrhea associated with Vasoactive Intestinal Peptide secreting tumors, and severe diarrhea/flushing episodes associated with metastatic carcinoid tumors. Viatris Inc. (NASDAQ:VTRS) also reported that the US FDA granted acceptance for review of the New Drug Application (NDA) for the company's investigational low dose estrogen weekly patch, comprising 150 mcg norelgestromin and 17.5 mcg ethinyl estradiol, for contraception. In addition, the US FDA cleared the company's Investigational New Drug (IND) application for MR-146, an Enriched Tear FilmTM (ETF) Adeno-Associated Virus (AAV) gene therapy candidate for the
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer [Yahoo! Finance]Yahoo! Finance
- Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs OfficerPR Newswire
- Assessing Idorsia (SWX:IDIA) Valuation After Recent Share Price Swings And Pipeline Developments [Yahoo! Finance]Yahoo! Finance
- A Look At Viatris (VTRS) Valuation After Recent Regulatory And Pipeline Milestones [Yahoo! Finance]Yahoo! Finance
- 1 Momentum Stock to Target This Week and 2 That Underwhelm [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 11/6/25 - Beat
VTRS
Sec Filings
- 1/2/26 - Form 4
- 12/8/25 - Form 8-K
- 12/5/25 - Form 8-K
- VTRS's page on the SEC website